AI assistant
DEXCOM INC — Director's Dealing 2020
Mar 14, 2020
30198_dirs_2020-03-13_a0dc8b1b-0cd5-471a-bb0e-247b6c1c221e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-03-11
Reporting Person: Selvaraj Shelly Ramasamy (SVP Information Technology)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-03-11 | Common Stock | S | 60 | $245.6175 | Disposed | 30335 | Direct |
| 2020-03-11 | Common Stock | S | 35 | $246.2111 | Disposed | 30300 | Direct |
| 2020-03-11 | Common Stock | S | 40 | $250.2028 | Disposed | 30260 | Direct |
| 2020-03-11 | Common Stock | S | 3252 | $265.426 | Disposed | 27008 | Direct |
Footnotes
F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2: This transaction was executed in multiple trades at prices ranging from $245.11 to $246.01. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3: Included in this number are 19,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 3,000 of which of were granted on May 22, 2016 and shall vest through May 22, 2020.
F4: This transaction was executed in multiple trades at prices ranging from $246.2053 to $246.385. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.